Nuvo Pharmaceuticals Inc. (TSX:NRI; OTCQX:NRIFF) d/b/a Miravo Healthcare (Miravo or the Company) is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products.  The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology.  The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.  Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada.  The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration.  



Contact Information
Investor Relations Contact
Stefan Eftychiou
905 326 1888 ext 60
[email protected]

Latest

Sep 07, 2021, 07:30 ET Miravo Healthcare™ Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference

- September 13-15, 2021 (Virtual Conference) - MISSISSAUGA, ON, Sept. 7, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:MRV) (OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...

Aug 12, 2021, 07:30 ET Miravo Healthcare™ Announces Receipt of Health Canada Notice of Compliance for the Pediatric Use of Blexten®

- Blexten Label Expanded to Include Ages as Young as 4 Years Old - - Includes Approval of 2.5mg/mL Oral Solution and 10mg orodispersible (Quick Melt) Tablet Formats - - Commercial Availability of...

Aug 09, 2021, 07:30 ET Miravo Healthcare™ Announces Second Quarter 2021 Results

- Q2 2021 Adjusted Total Revenue - $19.9 million - - Q2 2021 Adjusted EBITDA - $7.4 million - - Blexten Canadian Prescriptions Increased 26% Year-Over-Year - - Cambia Canadian Prescriptions Increased ...

Jul 29, 2021, 17:05 ET Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea

- First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - MISSISSAUGA, ON, July 29, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: NRI) (OTCQX: NRIFF) d/b/a ...

Jul 26, 2021, 07:30 ET Miravo Healthcare™ Announces Second Quarter 2021 Results Release Date and Conference Call Details

MISSISSAUGA, ON, July 26, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach...

Jul 08, 2021, 07:30 ET Miravo Healthcare™ to Present at Access to Giving Virtual Investor Conference

MISSISSAUGA, ON, July 8, 2021 /CNW/ - Nuvo Pharmaceuticals®Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and...

May 27, 2021, 07:30 ET Miravo Healthcare™ to Present at Summer Solstice - Best Ideas from the Buy Side

- Tuesday, June 1st – 3:30 p.m. ET - MISSISSAUGA, ON, May 27, 2021 /CNW/ - Nuvo Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused...

May 19, 2021, 17:00 ET Miravo Healthcare™ Announces Appointment of Mary Ritchie to its Board of Directors

MISSISSAUGA, ON, May 19, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and...

May 17, 2021, 14:46 ET Miravo Healthcare™ Announces Director Election Results of its Annual Meeting of Shareholders

MISSISSAUGA, ON, May 17, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company) a Canadian focused healthcare company with global reach and a ...

May 17, 2021, 07:30 ET Miravo Healthcare™ Announces First Quarter 2021 Results

- Q1 2021 Adjusted Total Revenue - $14.5 million - - Q1 2021 Adjusted EBITDA - $4.4 million - - Blexten Canadian Prescriptions Increased 22% Year-Over-Year - - Cambia Canadian Prescriptions Increased ...

May 11, 2021, 07:30 ET Miravo Healthcare™ to Present at Q2 Virtual Investor Summit

- Tuesday, May 18th – 2:00 p.m. ET - MISSISSAUGA, ON, May 11, 2021 /CNW/ - Nuvo Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused...

May 03, 2021, 07:30 ET Miravo Healthcare™ Announces First Quarter 2021 Results Release Date and Virtual Annual Meeting of Shareholders

MISSISSAUGA, ON, May 3, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and...

Apr 21, 2021, 17:00 ET Miravo Healthcare™ Files Final Base Shelf Prospectus

MISSISSAUGA, ON, April 21, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare ("Miravo" or "the Company") a Canadian focused healthcare company with global reach ...

Apr 09, 2021, 07:30 ET Miravo Healthcare™ to Present at Upcoming Investor Conferences

• Bloom Burton & Co. Healthcare Investor Conference - April 21st at 10:00 a.m. EST • • Planet MicroCap Showcase - April 22nd at 10:00 a.m. EST • MISSISSAUGA, ON, April 9, 2021 /CNW/ - April 9, 2021 – ...

Mar 26, 2021, 10:00 ET Miravo Healthcare™ Acknowledged In The Globe and Mail's Second-Annual Women Lead Here Benchmark of Executive Gender Diversity

MISSISSAUGA, ON, March 26, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach...

Mar 11, 2021, 07:30 ET Miravo Healthcare™ to Present at Q1 Virtual Investor Summit

- Wednesday, March 24th - 3:30 p.m. EST - MISSISSAUGA, ON, March 11, 2021 /CNW/ - Nuvo Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian...

Mar 08, 2021, 17:00 ET Miravo Healthcare™ Files Preliminary Base Shelf Prospectus

MISSISSAUGA, ON, March 8, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare ("Miravo" or "the Company") a Canadian focused healthcare company with global reach...

Mar 08, 2021, 07:30 ET Miravo Healthcare™ Announces 2020 and Fourth Quarter Results

- Fiscal Year 2020 Adjusted Total Revenue - $71.0 million - - Fiscal Year 2020 Adjusted EBITDA - $28.4 million - - Blexten Canadian Prescriptions Increased 35% Year-Over-Year - - Cambia Canadian...

Mar 01, 2021, 07:30 ET Miravo Healthcare™ Ireland Enters into Resultz® License and Supply Agreement with The Mentholatum Company for the United States

- Commercial launch anticipated in Summer 2021 - MISSISSAUGA, ON, March 1, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian ...

Feb 22, 2021, 07:30 ET Miravo Healthcare™ Announces Fourth Quarter 2020 Results Release Date and Conference Call Details

MISSISSAUGA, ON, Feb. 22, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and ...

Jan 14, 2021, 07:30 ET Miravo Healthcare™ to Host Investor Webcast on January 28, 2021 at 2:00 p.m. EST

MISSISSAUGA, ON, Jan. 14, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and ...

Jan 13, 2021, 07:30 ET Miravo Healthcare™ Announces the Canadian Commercial Launch of NeoVisc®+ and NeoVisc® ONE for the Treatment of Pain and Improvement of Joint Functionality of the Knee

MISSISSAUGA, ON, Jan. 13, 2021 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and ...

Dec 21, 2020, 07:30 ET Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets

- First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments - MISSISSAUGA, ON, Dec. 21, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX: NRI) (OTCQX: NRIFF)...

Dec 18, 2020, 07:30 ET Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™

- Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON, Dec. 18, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:NRI) (OTCQX:NRIFF) d/b/a Miravo Healthcare (Miravo or the Company), a...

Nov 16, 2020, 07:30 ET Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results

- Q3 2020 Adjusted Total Revenue - $16.7 million - - Q3 2020 Adjusted EBITDA - $6.6 million - - Blexten Canadian Prescriptions Increased 30% Year-Over-Year - - Cambia Canadian Prescriptions Increased ...

Journalists and Bloggers

The news you need, when you need it.

Join PR Newswire for Journalists to access all of the free services designated to make your job easier.

In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.

LEARN MORE